Palisade Bio, Inc. (PALI)
2.01
-0.04
(-1.95%)
USD |
NASDAQ |
Sep 10, 16:00
2.05
+0.04
(+1.99%)
After-Hours: 20:00
Palisade Bio Price to Book Value : 2.866 for Sept. 10, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 10, 2026 | 2.866 |
| September 09, 2026 | 2.923 |
| September 08, 2026 | 3.137 |
| September 04, 2026 | 2.980 |
| September 03, 2026 | 2.916 |
| September 02, 2026 | 2.838 |
| September 01, 2026 | 2.795 |
| August 31, 2026 | 2.780 |
| August 28, 2026 | 2.852 |
| August 27, 2026 | 3.009 |
| August 26, 2026 | 3.037 |
| August 25, 2026 | 2.952 |
| August 24, 2026 | 2.866 |
| August 21, 2026 | 2.994 |
| August 20, 2026 | 2.937 |
| August 19, 2026 | 3.080 |
| August 18, 2026 | 2.909 |
| August 17, 2026 | 3.066 |
| August 14, 2026 | 3.051 |
| August 13, 2026 | 3.066 |
| August 12, 2026 | 2.795 |
| August 11, 2026 | 3.051 |
| August 10, 2026 | 2.994 |
| August 07, 2026 | 3.009 |
| August 06, 2026 | 2.980 |
| Date | Value |
|---|---|
| August 05, 2026 | 3.023 |
| August 04, 2026 | 2.952 |
| August 03, 2026 | 2.766 |
| July 31, 2026 | 2.702 |
| July 30, 2026 | 2.795 |
| July 29, 2026 | 2.795 |
| July 28, 2026 | 2.880 |
| July 27, 2026 | 2.894 |
| July 24, 2026 | 2.780 |
| July 23, 2026 | 2.880 |
| July 22, 2026 | 2.709 |
| July 21, 2026 | 2.738 |
| July 20, 2026 | 2.723 |
| July 17, 2026 | 2.809 |
| July 16, 2026 | 2.695 |
| July 15, 2026 | 2.894 |
| July 14, 2026 | 2.752 |
| July 13, 2026 | 2.695 |
| July 10, 2026 | 2.795 |
| July 09, 2026 | 2.809 |
| July 08, 2026 | 2.923 |
| July 07, 2026 | 2.966 |
| July 06, 2026 | 2.909 |
| July 02, 2026 | 2.994 |
| July 01, 2026 | 2.809 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.654 |
| Alnylam Pharmaceuticals, Inc. | 24.44 |
| Anika Therapeutics, Inc. | 2.046 |
| Savara, Inc. | 7.606 |
| Vericel Corp. | 5.237 |
Price to Book Value Related Metrics
| PS Ratio | 590.90 |
| Price | 2.01 |
| Earnings Yield | -26.63% |
| Market Cap | 348.93M |